Open AccessCARFILZOMIB AND LULIZUMAB-BASED DESENSITIZATION PROLONGS ALLOGRAFT SURVIVAL IN SENSITIZED NON-HUMAN PRIMATES KIDNEY TRANSPLANTATION MODEL
Author(s) -
Paul M. Schroder,
Robin Schmitz,
Zachary W. Fitch,
Brian Ezekian,
Janghoon Yoon,
Mingqing Song,
Alton B. Farris,
Ashley Y. Choi,
Andrew S. Barbas,
F. Leopardi,
Bradley H. Collins,
Jean Kwun,
Stuart J. Knechtle
Publication year - 2020
Publication title -
transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.45
H-Index - 204
eISSN - 1534-6080
pISSN - 0041-1337
DOI - 10.1097/01.tp.0000698484.85894.27
Subject(s) - carfilzomib , belatacept , medicine , immunology , cd20 , transplantation , kidney transplantation , desensitization (medicine) , pharmacology , antigen , receptor , proteasome inhibitor , multiple myeloma , kidney transplant